Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.15
-0.43 (-3.71%)
Mar 17, 2026, 3:06 PM EDT - Market open
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $307.26 million as of March 17, 2026.
Market Cap
307.26M
Enterprise Value
107.01M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $307.26M, a decrease of -0.50%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 384.62M | 65.88% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 326.50M |
| NovaBridge Biosciences | 326.27M |
| Silence Therapeutics | 325.91M |
| X4 Pharmaceuticals | 322.64M |
| XOMA Royalty | 313.62M |
| Context Therapeutics | 308.71M |
| AC Immune | 306.85M |
| Polaryx Therapeutics | 301.10M |